151 related articles for article (PubMed ID: 15380837)
1. The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats.
Zhu H; Barr GA
Int J Dev Neurosci; 2004; 22(5-6):379-95. PubMed ID: 15380837
[TBL] [Abstract][Full Text] [Related]
2. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
Rasmussen K
Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
[TBL] [Abstract][Full Text] [Related]
3. Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-n-methyl-D-aspartate receptors.
Garcia MM; Anderson AT; Edwards R; Harlan RE
Neuroscience; 2003; 119(3):787-94. PubMed ID: 12809699
[TBL] [Abstract][Full Text] [Related]
4. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence.
Fundytus ME; Coderre TJ
Br J Pharmacol; 1994 Dec; 113(4):1215-20. PubMed ID: 7889275
[TBL] [Abstract][Full Text] [Related]
5. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
[TBL] [Abstract][Full Text] [Related]
6. Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.
Russell SE; Puttick DJ; Sawyer AM; Potter DN; Mague S; Carlezon WA; Chartoff EH
J Neurosci; 2016 May; 36(21):5748-62. PubMed ID: 27225765
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Zhu H; Barr GA
Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
[TBL] [Abstract][Full Text] [Related]
9. Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats.
Kawasaki Y; Ishida S; Jin C; Kitamura Y; Kawasaki H; Gomita Y; Sendo T; Araki H
Eur J Pharmacol; 2011 Sep; 666(1-3):131-4. PubMed ID: 21635886
[TBL] [Abstract][Full Text] [Related]
10. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
13. Opiate withdrawal induces dynamic expressions of AMPA receptors and its regulatory molecule CaMKIIalpha in hippocampal synapses.
Zhong W; Dong Z; Tian M; Cao J; Xu T; Xu L; Luo J
Life Sci; 2006 Jul; 79(9):861-9. PubMed ID: 16616767
[TBL] [Abstract][Full Text] [Related]
14. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
15. Opiate physical dependence and N-methyl-D-aspartate receptors.
Noda Y; Nabeshima T
Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
[TBL] [Abstract][Full Text] [Related]
16. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
Bristow LJ; Hogg JE; Hutson PH
Neuropharmacology; 1997 Feb; 36(2):241-50. PubMed ID: 9144662
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.
Luccini E; Musante V; Neri E; Brambilla Bas M; Severi P; Raiteri M; Pittaluga A
Br J Pharmacol; 2007 Aug; 151(7):1087-94. PubMed ID: 17592518
[TBL] [Abstract][Full Text] [Related]
18. Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus.
Elhussiny MEA; Carini G; Mingardi J; Tornese P; Sala N; Bono F; Fiorentini C; La Via L; Popoli M; Musazzi L; Barbon A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110033. PubMed ID: 32640261
[TBL] [Abstract][Full Text] [Related]
19. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
Rasmussen K; Martin H; Berger JE; Seager MA
Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
[TBL] [Abstract][Full Text] [Related]
20. Opiate withdrawal during development: are NMDA receptors indispensable?
Zhu H; Barr GA
Trends Pharmacol Sci; 2001 Aug; 22(8):404-8. PubMed ID: 11479002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
